IMUX Earnings IMMUNIC, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.08 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -0.62 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | -0.55 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.45 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.51 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -1.00 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | -0.75 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.51 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.30 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -2.11 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -1.63 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.12 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.58 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -3.78 | 2024-02-22 | 10-K |
| Q3 2023 | 2022-09-30 | -2.16 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.49 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.74 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -3.93 | 2023-02-23 | 10-K |
| Q3 2022 | 2021-09-30 | -3.33 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -2.44 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.